In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Cancer Type/Condition:  Thyroid cancer
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02530, UCCRC-10-182-B, CDR0000685236, 10-182-B, 8317, N01CM00032, N01CM62201, N01CM00038, P30CA014599, N01CM00071, NCT01208051

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 110027, 11-C-0027, NCT01240590

3.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 100041, 10-C-0041, NCT01182285

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00554, RU241210I, OSU 12154, 9312, P30CA016058, N01CM00039, N01CM00071, N01CM00070, NCT01811212

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130108, 13-C-0108, NCT01838642

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00831, ALLIANCE A021202, CALGB-A021202, A021202, U10CA180821, U10CA031946, NCT01841736

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 to 70
Sponsor: NCI, Other
Protocol IDs: UW13115, NCI-2014-00833, R01CA176911, P30CA014520, 2014-0391, NCT02138214

8.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other, Pharmaceutical / Industry
Protocol IDs: A091302, U10CA031946, U10CA180821, NCI-2014-00623, NCT02143726

9.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A091305, U10CA031946, U10CA180821, NCI-2014-00686, NCT02152137

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01106, 13-157, 9446, U01CA069856, P30CA008748, NCT02152995

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 18
Sponsor: NCI
Protocol IDs: NCI-2012-01890, CDR0000741914, 13-C-0042, P121149, NCI-2013-01571, COG-ADVL1211, ADVL1211, U01CA097452, NCT01709435

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GI-6207-02, NCT01856920

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-01748, 9354, 13-061, U01CA069856, P30CA008748, NCT01947023
New Search